PEN
Penumbra Inc
NYSE · Healthcare · Medical - Devices · US
$324.05
+0.51%Forward multiples
Based on analyst estimates
- P/E forward
- 54.79x
- P/E 2026E
- 68.18x
- P/E 2027E
- 54.09x
- P/E 2028E
- 46.38x
- P/S forward
- 7.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- 79.23x
- PEG TTM
- 1.78x
- Price / book
- 8.34x
- Price / sales
- 8.48x
- Price / cash flow
- 45.95x
Enterprise value
- Enterprise value
- $12.3B
- EV / sales
- 8.19x
- EV / EBITDA
- 55.42x
- EV / EBIT
- 65.75x
- Market cap
- $12.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026